NCT01858883View on ClinicalTrials.gov

Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

February 29, 2016

Study Completion Date

March 31, 2016

Conditions
Solid TumorsPancreatic Cancer
Interventions
DRUG

itacitinib

DRUG

Gemcitabine

DRUG

nab-paclitaxel

DRUG

filgrastim

Trial Locations (8)

Unknown

Scottsdale

Fayetteville

Beverly Hills

Southington

Indianapolis

Baltimore

Lake Success

Philadelphia

Sponsors

Lead Sponsor

Incyte Corporation
All Listed Sponsors
lead

Incyte Corporation

INDUSTRY